Skip to content
Nanopharm-logo-with-signature-Pantone (1)
  • Home
  • SmartTrackā„¢
  • About Us

    About Us

    Leadership Team

    Our Scientists

    Locations

  • Services

    Product Development

    Preformulation & Preclinical

    Spray Drying & Particle Engineering

    Formulation & Drug Product Development

    Clinical Development

    Clinical Trial Manufacturing

    cGMP Release & Stability Testing

    Clinical Labeling

    Analytical Services

    Research & Development

    Spray Characterization

    Method Development
    cGMP Release & Stability

    IVBE & CMC Studies

    Alternative Bioequivalence

    In-Silico Modeling

    PBPK Modeling Regional Deposition Modeling

    Regulatory

    Consultancy

    Alternative Bioequivalence
  • OINDP Expertise

    Nasal

    Nasal Powders

    Nasal Sprays

    Nasal Cast Deposition

    Inhalation

    DPI

    pMDI

    Low GWP Propellant pMDI

    Nebulizers

    Inhaled Biologics

    Generics & Lifecycle Management

    Reformulation & Repositioning

    IVBE

    Alternative Bioequivalence
  • Resources

    Resources

    Scientific Publications

    White Papers

    Posters
  • News & Events
  • Contact Us
  • Careers

Tag: Molecular SFE

Elucidating Molecular- and Particle-Level Changes during the Annealing of a Micronized Crystalline Drug

Nanopharm explores annealing in micronized DPIs for drug development. Focus on molecular changes and SFE in Dry Powder Inhaler formulations.

Nanopharm logo

Transforming bioequivalence for orally inhaled and nasal drug products through advanced in vitro and in silico modeling.

Platform

  • OINDP Expertise
  • About Us
  • Services

Resources

  • Scientific Publications
  • White Papers
  • Posters
  • News Events

Contact

Nanopharm Ltd
Franklin House, Grange Road, Cwmbran, NP44 3WY, United Kingdom

info@nanopharm.co.uk
+44 (0) 1633 372200

Ā© 2026 Nanopharm Ltd, an Aptar Pharma Company. All rights reserved.

Privacy PolicyTerms of Service